{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:25:19Z","timestamp":1740176719513,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00261-022-03448-x","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T14:04:35Z","timestamp":1646316275000},"page":"2230-2237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Split-bolus CT urography after microwave ablation of renal cell carcinoma improves image quality and reduces radiation exposure"],"prefix":"10.1007","volume":"47","author":[{"given":"Alex P.","family":"Tannenbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan G.","family":"Lubner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Mithqal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Ziemlewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn O.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Brace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jason Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Mankowski-Gettle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah S.","family":"Schenkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1067-6624","authenticated-orcid":false,"given":"Shane A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"issue":"1","key":"3448_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75 (1):74-84.","journal-title":"Eur Urol"},{"issue":"6","key":"3448_CR2","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00261-016-1037-8","volume":"42","author":"SA Wells","year":"2017","unstructured":"Wells SA, Wong VK, Wittmann TA, et al (2017) Renal mass biopsy and thermal ablation: Should biopsy be performed before or during the ablation procedure? Abdom Radiol (NY) 42 (6):1773-1780.","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"3448_CR3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/JU.0000000000000113","volume":"201","author":"NM Posielski","year":"2019","unstructured":"Posielski NM, Bui A, Wells SA, et al (2019) Risk factors for complications and nondiagnostic results following 1,155 consecutive percutaneous core renal mass biopsies. J Urol 201 (6):1080-1087.","journal-title":"J Urol"},{"issue":"11","key":"3448_CR4","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1007\/s00330-019-06121-y","volume":"29","author":"KA Maciolek","year":"2019","unstructured":"Maciolek KA, Abel EJ, Posielski NM, et al (2019) Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma. Eur Radiol 29 (11):6319-6329.","journal-title":"Eur Radiol"},{"issue":"3","key":"3448_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","volume":"198","author":"S Campbell","year":"2017","unstructured":"Campbell S, Uzzo RG, Allaf ME, et al (2017) Renal mass and localized renal cancer: AUA Guideline. J Urol 198 (3):520-529.","journal-title":"J Urol"},{"issue":"4","key":"3448_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","volume":"196","author":"PM Pierorazio","year":"2016","unstructured":"Pierorazio PM, Johnson MH, Patel HD, et al (2016) Management of renal masses and localized renal cancer: Systematic review and meta-analysis. J Urol 196 (4):989-999.","journal-title":"J Urol"},{"issue":"3","key":"3448_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.eururo.2012.08.062","volume":"63","author":"SP Psutka","year":"2013","unstructured":"Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63 (3):486-492.","journal-title":"Eur Urol"},{"issue":"2","key":"3448_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.eururo.2019.04.026","volume":"76","author":"JR Andrews","year":"2019","unstructured":"Andrews JR, Atwell T, Schmit G, et al (2019) Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 76 (2):244-251.","journal-title":"Eur Urol"},{"issue":"2","key":"3448_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2018180249","volume":"289","author":"DJ Breen","year":"2018","unstructured":"Breen DJ, King AJ, Patel N, Lockyer R, Hayes M (2018) Image-guided cryoablation for sporadic renal cell carcinoma: Three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289 (2):554-561.","journal-title":"Radiology"},{"issue":"3","key":"3448_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiol.2020190919","volume":"294","author":"J Yu","year":"2020","unstructured":"Yu J, Zhang X, Liu H, et al (2020) Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: A propensity-matched cohort study of 1955 patients. Radiology 294 (3):698-706.","journal-title":"Radiology"},{"issue":"5","key":"3448_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1109\/MPUL.2011.942603","volume":"2","author":"C Brace","year":"2011","unstructured":"Brace C (2011) Thermal tumor ablation in clinical use. IEEE Pulse 2 (5):28-38.","journal-title":"IEEE Pulse"},{"issue":"11","key":"3448_CR12","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jvir.2014.06.013","volume":"25","author":"TD McClure","year":"2014","unstructured":"McClure TD, Chow DS, Tan N, Sayre JA, Pantuck AJ, Raman SS (2014) Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. J Vasc Interv Radiol 25 (11):1682-1688.","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"3448_CR13","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1007\/s00330-020-07613-y","volume":"31","author":"NE Curci","year":"2021","unstructured":"Curci NE, Triche BL, Abel EJ, et al (2021) Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation. Eur Radiol 31 (8):5490-5497.","journal-title":"Eur Radiol"},{"key":"3448_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/RCT.0b013e318033df36","volume":"31","author":"JR Dillman","year":"2007","unstructured":"Dillman JR, Caoili EM, Cohan RH, et al (2007) Comparison of urinary tract distention and opacification using single-bolus 3-phase vs split-bolus 2-phase multidetector row CT urography. J Comput Assist Tomogr 31:750-757.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"3448_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.juro.2008.10.024","volume":"181","author":"LJ Wang","year":"2009","unstructured":"Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST (2009) Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181 (2):524-531.","journal-title":"J Urol"},{"issue":"6","key":"3448_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1120\/jacmp.v17i6.6184","volume":"17","author":"L Page","year":"2016","unstructured":"Page L, Wei W, Kundra V, Rong XJ (2016) Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction. J Appl Clin Med Phys 17 (6):334-342.","journal-title":"J Appl Clin Med Phys"},{"issue":"3","key":"3448_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","volume":"182","author":"A Kutikov","year":"2009","unstructured":"Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantifying renal tumor size, location and depth. J Urol 182 (3):844-853.","journal-title":"J Urol"},{"key":"3448_CR18","doi-asserted-by":"crossref","unstructured":"Boone J, Strauss K. Cody D, McCollough C, et al (2011) Size-specific dose estimates (SSDE) in pediatric and adult body CT examinations. Report of AAPM Task Group 204.","DOI":"10.37206\/143"},{"issue":"1","key":"3448_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL, et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273 (1):241-260.","journal-title":"Radiology"},{"issue":"8","key":"3448_CR20","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s00261-015-0500-2","volume":"40","author":"J Yu","year":"2015","unstructured":"Yu J, Zhang G, Liang P, et al (2015) Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radical nephrectomy for small renal cell carcinoma. Abdom Imaging 40 (8):3248-3256.","journal-title":"Abdom Imaging"},{"key":"3448_CR21","doi-asserted-by":"crossref","unstructured":"Koebe SD, Curci NE, Caoili EM et al (2022) Contrast enhanced CT immediately following microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes. Abdom Radiol (in press)","DOI":"10.1007\/s00261-022-03481-w"},{"issue":"9","key":"3448_CR22","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1007\/s00261-020-02662-9","volume":"45","author":"KA Wetley","year":"2020","unstructured":"Wetley KA, Abel EJ, Dreyfuss LE, Huang W, Brace CL, Wells SA (2020) CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol 45 (9):2810-2824.","journal-title":"Abdom Radiol"},{"issue":"1","key":"3448_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1148\/radiol.2016160592","volume":"284","author":"ME Klapperich","year":"2017","unstructured":"Klapperich ME, Abel EJ, Ziemlewicz TJ, et al (2017) Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: A single-center, retrospective study. Radiology 284 (1): 272-280.","journal-title":"Radiology"},{"issue":"2","key":"3448_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2214\/AJR.15.14821","volume":"206","author":"H Takaki","year":"2016","unstructured":"Takaki H, Nakatsuka A, Cornellis et al (2016) False-positive tumor enhancement after cryoablation of renal cell carcinoma: A prospective study. AJR Am J Roentgenol 206 (2):332-339.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"3448_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2214\/AJR.12.8618","volume":"200","author":"TD Atwell","year":"2013","unstructured":"Atwell TD, Schmit GD, Boorjian SA, et al (2013) Percutaneous ablation of renal massess measuring 3.0 cm and smaller: Comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 200 (2):461-466.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"3448_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00261-016-0776-x","volume":"41","author":"SA Wells","year":"2016","unstructured":"Wells SA, Wheeler KM, Mithqal A, Patel MS, Brace CL, Schenkman NS (2016) Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: Short-term efficacy and complications with emphasis on tumor complexity and single-session treatment. Abdom Radiol 41 (6):1203-1211.","journal-title":"Abdom Radiol"},{"issue":"3","key":"3448_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2214\/ajr.173.3.10470916","volume":"173","author":"BI Yuh","year":"1999","unstructured":"Yuh BI, Cohan RH (1999) Different phases of renal enhancement: Role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol 173 (3):747-755.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"3448_CR28","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1148\/rg.285075744","volume":"28","author":"GM Israel","year":"2008","unstructured":"Israel GM, Bosniak MA (2008) Pitfalls in renal mass evaluation and how to avoid them. Radiographics 28 (5):1325-1338.","journal-title":"Radiographics"},{"issue":"6","key":"3448_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/RCT.0000000000001215","volume":"45","author":"TP Szczykutowicz","year":"2021","unstructured":"Szczykutowicz TP, Viggiano B, Rose S, Pickhardt PJ, Lubner MG (2021) A metric for quantification of iodine contrast enhancement (Q-ICE) in computed tomography. J Comput Assist Tomogr 45 (6):870-876.","journal-title":"J Comput Assist Tomogr"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03448-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T11:04:18Z","timestamp":1652526258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03448-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3448"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03448-x","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"1 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript declare relationships with the following companies: Timothy J. Ziemlewicz: Ethicon Inc, Consultant; Histosonics, Research support and shapreholder. Christopher L. Brace: Ethicon Inc, Consultant, Elucent Medical Inc., Shareholder; Symple Surgical Inc., Shareholder. Lori Mankowski-Gettle: GE and Siemens, Research support; Elucent Medical Inc., Shareholder. Shane A. Wells: Ethicon Inc., Consultant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Authors consent for consideration of publication in Abdominal Radiology.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}